Best Momentum Stocks to Buy for April 7th

The US-Iran war has sent shockwaves far beyond the “Strait of Hormuz”, landing squarely on Wall Street. As the conflict continues, the global economy faces a dual-threat environment: rising energy costs and a massive pivot toward defense spending.

CVS Health is slowly righting the ship after several challenging years. Abbott Laboratories’ strong business should improve thanks to an acquisition.

The Strait of Hormuz disruption could keep oil prices elevated longer than a typical supply shock due to shipping/insurance constraints, limited SPR flexibility, and already-tightening fundamentals. ExxonMobil and Devon Energy could translate higher oil into outsized free cash flow, including Exxon’s advantaged production and LNG ramp and Devon’s Coterra merger synergies plus a potential dividend step-up.